癌症
转录组
计算生物学
癌变
生物信息学
体内
细胞生物学
基因
肿瘤微环境
作者
Xiphias Ge Zhu,Aleksey Chudnovskiy,Lou Baudrier,Benjamin Prizer,Yuyang Liu,Benjamin N. Ostendorf,Norihiro Yamaguchi,Abolfozl Arab,Bernardo Tavora,Rebecca C. Timson,Søren Heissel,Elisa de Stanchina,Henrik Molina,Gabriel D. Victora,Hani Goodarzi,Kıvanç Birsoy
标识
DOI:10.1016/j.cmet.2020.10.017
摘要
Summary Pancreatic ductal adenocarcinoma (PDAC) cells require substantial metabolic rewiring to overcome nutrient limitations and immune surveillance. However, the metabolic pathways necessary for pancreatic tumor growth in vivo are poorly understood. To address this, we performed metabolism-focused CRISPR screens in PDAC cells grown in culture or engrafted in immunocompetent mice. While most metabolic gene essentialities are unexpectedly similar under these conditions, a small fraction of metabolic genes are differentially required for tumor progression. Among these, loss of heme synthesis reduces tumor growth due to a limiting role of heme in vivo, an effect independent of tissue origin or immune system. Our screens also identify autophagy as a metabolic requirement for pancreatic tumor immune evasion. Mechanistically, autophagy protects cancer cells from CD8+ T cell killing through TNFα-induced cell death in vitro. Altogether, this resource provides metabolic dependencies arising from microenvironmental limitations and the immune system, nominating potential anti-cancer targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI